diagnostic criteria for, 338–339
diagnostic features of, 339–340
diagnostic markers for, 342–343
differential diagnosis of, 344
functional consequences of, 343
prevalence of, 341
risk and prognostic factors for, 342
subtypes of, 339
suicide risk in, 343
Antidepressant discontinuation syndrome, 22, 
712–714
comorbidity with, 714
course and development of, 713diagnostic features of, 713
differential diagnosis of, 713–714
prevalence of, 713
Antisocial personality disorder, 461, 476, 645, 646, 
659–663
associated features supporting diagnosis of, 
660–661
culture-related diagnostic issues in, 662
development and course of, 661
diagnostic criteria for, 659
diagnostic features of, 659–660
differential diagnosis of, 662–663
features and criteria in alternative DSM-5 
model for personality disorders, 763, 
764–765
gender-related diagnostic issues in, 662
prevalence of, 661
risk and prognostic factors for, 661–662
Anxiety disorder due to another medical 
condition, 190, 230–232
associated features supporting diagnosis of, 
231
development and course of, 231
diagnostic criteria for, 230
diagnostic features of, 230–231
diagnostic markers for, 231
differential diagnosis of, 231–232
prevalence of, 231
Anxiety disorders, 189–264
agoraphobia, 190, 217–221
anxiety disorder due to another medical 
condition, 190, 230–232